Record‑Setting Donations, Yet Half of Kidney Candidates Never Reach Evaluation
The United States celebrated a historic surge in organ donations in 2022, with new policies and technology promising faster, fairer transplants [2]. But a sobering counter‑point has emerged: almost half of Americans referred for a kidney transplant never even begin the lengthy evaluation required to join the waiting list [3]. While living‑donor liver stories shine a human light on the system’s successes, they also underscore the gaps that keep many patients from getting a foot in the door [1].
Key takeaways
- The U.S. hit an all‑time high in organ donors in 2022, thanks to policy tweaks and broader public awareness [2].
- Despite these gains, nearly 50 % of people with kidney failure who are referred for transplantation never start the evaluation process [3].
- Living liver donors and recipients share personal narratives that illustrate both the triumphs of modern transplant pathways and the lingering barriers patients face [1].
- Structural issues remain major roadblocks for kidney candidates [3].
A year of milestones
2022 was hailed as a watershed moment for organ donation [2]. New federal initiatives and expanded public‑education campaigns helped push the number of donors past previous records [2].
The evaluation cliff for kidney patients
A recent analysis revealed that almost one‑in‑two adults with end‑stage kidney disease who are referred for transplant never move beyond the first step: initiating the comprehensive evaluation [3].
Living donor stories highlight the human side
While kidney candidates stumble, living liver donors and recipients are sharing their journeys in a new series called “LIVE ON: Real Stories of Living Liver Donors and Recipients” [1]. The program follows three recipients and four donors, illustrating how modern transplant pathways can enable life‑saving surgeries [1].
Why the disconnect matters now
Dialysis remains the default therapy for most kidney failure patients [3]. The fact that half of referred patients never start evaluation means that a substantial portion of the potential transplant‑eligible population stays on dialysis [3].
Bottom line
The surge in organ donations and the procedural upgrades of 2022 are undeniable victories for the transplant community [2]. Yet, for kidney patients, the journey from referral to evaluation remains fraught with obstacles that cause nearly half to drop out before they can even be listed [3]. Living donor liver stories remind us that when the system works, it can change lives dramatically [1].